CYP4F11
Cytochrome P450 4F11
Also known as: CP4FB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HBI6
- Gene
- CYP4F11
- Ensembl
- ENSG00000171903
- Chromosome
- 19
- Canonical length
- 524 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene, CYP4F11, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F2, is approximately 16 kb away. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
524 residues, UniProt reviewed canonical sequence.
>Q9HBI6|CYP4F11
1 MPQLSLSWLG LGPVAASPWL LLLLVGGSWL LARVLAWTYT FYDNCRRLQC FPQPPKQNWF
61 WGHQGLVTPT EEGMKTLTQL VTTYPQGFKL WLGPTFPLLI LCHPDIIRPI TSASAAVAPK
121 DMIFYGFLKP WLGDGLLLSG GDKWSRHRRM LTPAFHFNIL KPYMKIFNKS VNIMHDKWQR
181 LASEGSARLD MFEHISLMTL DSLQKCVFSF ESNCQEKPSE YIAAILELSA FVEKRNQQIL
241 LHTDFLYYLT PDGQRFRRAC HLVHDFTDAV IQERRCTLPT QGIDDFLKNK AKSKTLDFID
301 VLLLSKDEDG KELSDEDIRA EADTFMFEGH DTTASGLSWV LYHLAKHPEY QEQCRQEVQE
361 LLKDREPIEI EWDDLAQLPF LTMCIKESLR LHPPVPVISR CCTQDFVLPD GRVIPKGIVC
421 LINIIGIHYN PTVWPDPEVY DPFRFDQENI KERSPLAFIP FSAGPRNCIG QAFAMAEMKV
481 VLALTLLHFR ILPTHTEPRR KPELILRAEG GLWLRVEPLG ANSQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP4F11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 67 nTPM
Expression across tissuesHPA
Tissue
- liver: 67 nTPM
- small intestine: 22 nTPM
- gallbladder: 18 nTPM
- epididymis: 16 nTPM
- esophagus: 12 nTPM
- duodenum: 10 nTPM
Single-cell type
- hepatocytes: 68 nCPM
- urothelial cells: 64 nCPM
- prostatic hillock cells: 24 nCPM
- esophageal apical cells: 23 nCPM
- epididymal principal cells: 21 nCPM
- bergmann glia: 20 nCPM
Immune cell
- basophil: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 27 nTPM
- medulla oblongata: 26 nTPM
- thalamus: 20 nTPM
- hypothalamus: 18 nTPM
- amygdala: 17 nTPM
- basal ganglia: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.52
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.4
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arachidonate metabolic process
- blood coagulation
- cytochrome metabolic process
- fatty acid metabolic process
- menaquinone catabolic process
- omega-hydroxylase P450 pathway
- oxylipin biosynthetic process
- phylloquinone catabolic process
- vitamin K catabolic process
Molecular functions
- arachidonate omega-hydroxylase activity
- fatty acid binding
- heme binding
- iron ion binding
- long-chain fatty acid omega-hydroxylase activity
- monooxygenase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP4F11 as an antibody target. Whether an autoantibody or antibody against CYP4F11 could matter depends on whether native CYP4F11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP4F11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP4F11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...